-
-
-
-
-
-
-
Mirum receives Health Canada approval for LIVMARLI tablet formulation
-
-
-
-
-
-
-
Mirum launches phase 2 trial for Fragile X syndrome treatment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)
-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Tops Q3 EPS by 20c ; Offers Guidance
-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Tops Q2 EPS by 21c
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
FDA approves Mirum Pharmaceuticals' (MIRM) genetic disorder drug
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

